Public-registry site landscape for NCT05181540, a Hodgkin Lymphoma study sponsored by Angiocrine Bioscience. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05181540 (registry record) |
| Sponsor | Angiocrine Bioscience |
| Condition(s) | Hodgkin Lymphoma; Non Hodgkin Lymphoma |
| Phase | PHASE3 |
| Listed sites | 28 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05181540 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →